Page 27 - HSP - MyOwnSkin Booklet 6_2020 Booklet RV2
P. 27

MyOwn Skin™ CPT Coding Guide

               MyOwn Skin™ is an autologous partial-thickness skin graft intended for homologous uses of skin tissues which may include the repair,
                reconstruction, replacement, or supplementation of skin tissues and the integumentary system. Qualified medical providers may use
                MyOwn Skin™ to treat patients who have suffered from an event, disease, process or acquired deficit that results in the functional loss
                or void of skin tissues and the integumentary system in place of or in combination with split-thickness grafting, full-thickness grafting,
          2     temporizing skin coverage and/or skin substitute products.

          2
               2019 CODING GUIDE: INPATIENT HOSPITAL SETTING
               Hospital Inpatient Coding and Reimbursement Procedures Using MyOwn Skin™
               DRG Coding Information:
               Medicare uses a Prospective Payment System to reimburse hospitals for inpatient services based on Medicare Severity-Diagnosis-Related
               Group (MS-DRG) classification system. Services are classified into clinical cohesive groups that exhibit similar use of hospital resources.
               Hospitals receive a single payment for all services provided during an inpatient admission. Only one DRG is assigned. Assignment to the
               categories of Complication or Comorbidities (CCs) and/or Major Complications or Comorbidities (MCC) is influence by the medical record
               documentation describing the hospital admission. Potentially relevant MS-DRG codes for MyOwn Skin™ and the national average Medicare
               payment rate are listed below.





































        1.   The Medicare National Facility and Non-Facility Provider payments and RVUs provided in the table above are national averages and are to be used as reference only. The Medicare National Average
            Rates provided in the table above are approximate and are to be used as reference only.


                                 © 2019 BioLab Sciences, Inc. All rights reserved. All trademarks used herein are trademarks of their respective owners.
                                                                                                           V1.7
   22   23   24   25   26   27   28   29   30   31